Technical Analysis for BIO.B - Bio-Rad Laboratories, Inc. Class B

Grade Last Price % Change Price Change
grade A 208.0 0.00% 0.00
BIO.B closed unchanged on Thursday, April 27, 2017, on 3 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical BIO.B trend table...

Date Alert Name Type % Chg
Apr 27 Narrow Range Bar Range Contraction 0.00%
Apr 27 Stochastic Reached Overbought Other 0.00%
Apr 27 Boomer Buy Setup Bullish Swing Setup 0.00%
Apr 27 Calm After Storm Range Contraction 0.00%
Apr 25 Narrow Range Bar Range Contraction 0.00%
Apr 25 Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
Apr 25 Calm After Storm Range Contraction 0.00%
Apr 21 New 52 Week High Bullish 0.00%
Apr 21 Volume Surge Other 0.00%
Apr 21 Gilligan's Island Sell Setup Bearish Swing Setup 0.00%

Older signals for BIO.B ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Is BIO.B a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 210.5
52 Week Low 135.0
Average Volume 201
200-Day Moving Average 166.3564
50-Day Moving Average 192.6844
20-Day Moving Average 199.0845
10-Day Moving Average 201.524
Average True Range 1.3644
ADX 47.05
+DI 83.68
-DI: 13.96
Chandelier Exit (Long, 3 ATRs) 206.4068
Chandelier Exit (Short, 3 ATRs) 194.8432
Upper Bollinger Band 209.1268
Lower Bollinger Band 189.0422
Percent B (%b) 0.94
Bandwidth 0.100885